Background: Identifying distinct mechanisms and biomarkers for painful diabetic peripheral neuropathy (DPN) is required for advancing the treatment of this major global unmet clinical need. We ...
Myelin seems to be the primary target of the immune attack in these disorders, although axonal variants are known ... The other type consists of vasculitic neuropathy (systemic or nonsystemic ...